BRIC Diabetes Care Devices Market Size, Share & Trends Analysis Report By Type (BGM Devices (Self-monitoring, Continuous monitoring), Insulin Delivery Devices (Pen, Pumps, Syringes, Jet Injectors)), And Segment Forecasts, 2019 - 2026

Published: Nov, 2019 | Pages: 110 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)

The BRIC diabetes care devices market size is projected to reach USD 4.82 million by 2026, according to a new report by Grand View Research, Inc. It is anticipated to register a 5.28% CAGR over the forecast period. The market in BRIC nations is primarily driven by the increasing prevalence of diabetes, especially among geriatric and obese population. Increasing collaboration and funding support to research is further augmenting the growth. The factors responsible for the increasing incidence of glucose impairment are the increasing alcohol and tobacco consumption, lack of physical activity, and obesity. However, increasing prices of advanced devices and presence of cost-effective alternative treatment may restrict the market growth.

BRIC nations are also witnessing large untapped opportunities with favorable government initiatives focused on disease awareness. According to the World Health Organization (WHO), more than 50% Indian population with diabetes remains undiagnosed. Many government initiatives and approval from the Food and Drug Administration (FDA) for advanced diabetes care devices are also propelling the growth. For instance, in 2019, the Research Trust of Diabetes India launched its 1000 days Initiative to control diabetes in the country. This initiative will bring together diabetologists across India to provide recommendations and clinical guidelines. Furthermore, technological advancements coupled with collaboration among key market players is also propelling the market growth. For instance, in September 2019, Abbott and Sanofi collaborated to work on tools that integrate Sanofi's insulin dosing information with Abbott's FreeStyle Libre technology.

Further key findings from the report suggest:

• Based on product, the insulin delivery devices dominated with over 60% market share in 2018. Insulin Pumps segment is expected to register the fastest CAGR of 3.81% during the forecast period owing to increasing number of patients with glucose impairments and availability of ease to use and convenient pumps

• On the basis of CGM devices, sensors dominated the segment with a revenue of over 100 million in 2018, attributed to high usage and adoption of these devices

• China held the dominant market position in 2018 and is expected to retain its lead throughout the forecast period. Large diabetes population and supportive government initiatives are the key factors driving market growth in the country

• Some of the prominent players in the BRIC diabetes care devices market include Johnson & Johnson; Ypsomed AG; Bayer AG; F. Hoffmann-La Roche Ltd; Abbott Laboratories; Becton, Dickinson and Company; Medtronic Plc; Ypsomed AG; Sanofi; Novo Nordisk A/S; Arkray, Inc.; Acon Laboratories, Inc.; Terumo Corporation; and Dexcom, Inc.

 Table of Contents

Chapter 1. Methodology and Scope
                  1.1. Market Segmentation & Scope
                      1.1.1. Product
                      1.1.2. Product Type
                      1.1.3. Country scope
                      1.1.4. Estimates and forecast timeline
                  1.2. Research Methodology
                  1.3. Information Procurement
                      1.3.1. Purchased database
                      1.3.2. GVR's internal database
                      1.3.3. Secondary sources
                      1.3.4. Primary research
                      1.3.5. Details of primary research
                  1.4. Information or Data Analysis
                      1.4.1. Data analysis models
                  1.5. Market Formulation & Validation
                  1.6. Model Details
                      1.6.1. Commodity flow analysis (Model 1)
                          1.6.1.1. Approach 1: Commodity flow approach
                      1.6.2. Volume price analysis (Model 2)
                          1.6.2.1. Approach 2: Volume price analysis
                  1.7. List of Secondary Sources
                  1.8. List of Primary Sources
                  1.9. Objectives
                      1.9.1. Objective 1
                      1.9.2. Objective 2

Chapter 2. Executive Summary
                  2.1. Market Outlook
                  2.2. Segment Outlook
                      2.2.1. Product outlook
                      2.2.2. Product type outlook
                      2.2.3. Country outlook
                  2.3. Competitive Insights

Chapter 3. BRIC Diabetes Care Devices Market Variables, Trends & Scope
                  3.1. Market Lineage Outlook
                      3.1.1. Parent market outlook
                      3.1.2. Related/ancillary market outlook
                  3.2. Penetration & Growth Prospect Mapping
                  3.3. Industry Value Chain Analysis
                      3.3.1. Reimbursement framework
                  3.4. Market Dynamics
                      3.4.1. Market driver analysis
                          3.4.1.1. Increasing number of diabetes patients
                          3.4.1.2. Technological advancement
                          3.4.1.3. Increasing awareness about diabetes preventive care
                      3.4.2. Market restraint analysis
                          3.4.2.1. High cost of devices
                      3.4.3. Industry challenges
                  3.5. BRIC Diabetes Care Devices Market Analysis Tools
                      3.5.1. Industry analysis - Porter's
                          3.5.1.1. Supplier power
                          3.5.1.2. Buyer power
                          3.5.1.3. Substitution threat
                          3.5.1.4. Threat of new entrant
                          3.5.1.5. Competitive rivalry
                      3.5.2. PESTEL analysis
                          3.5.2.1. Political landscape
                          3.5.2.2. Technological landscape
                          3.5.2.3. Economic landscape
                      3.5.3. Major deals & strategic alliances analysis
                      3.5.4. Market entry strategies

Chapter 4. Product Estimates & Trend Analysis
                  4.1. Definitions and Scope
                      4.1.1. Blood glucose monitoring
                          4.1.1.1. Self-monitoring devices
                              4.1.1.1.1. Blood glucose meters
                              4.1.1.1.2. Testing strips
                              4.1.1.1.3. Lancets
                          4.1.1.2. Continuous glucose monitoring devices
                              4.1.1.2.1. Sensors
                              4.1.1.2.2. Transmitters
                              4.1.1.2.3. Receiver
                      4.1.2. Insulin delivery devices
                          4.1.2.1. Insulin pens
                          4.1.2.2. Insulin pumps
                          4.1.2.3. Insulin syringes
                          4.1.2.4. Jet injectors

Chapter 5. BRIC Diabetes Care Devices Market: Country Estimates & Trend Analysis
                  5.1. Country Market Share Analysis, 2018 & 2026
                  5.2. County Market Dashboard
                  5.3. BRIC Country Market Snapshot
                  5.4. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2026:
                  5.5. Brazil
                      5.5.1. Market estimates and forecast, 2015 - 2026 (Value)
                  5.6. Russia
                      5.6.1. Russia Market estimates and forecast, 2015 - 2026 (Value)
                  5.7. India
                      5.7.1. Market estimates and forecast, 2015 - 2026 (Value)
                  5.8. China
                      5.8.1. Market estimates and forecast, 2015 - 2026 (Value)

Chapter 6. Competitive Landscape
                  6.1. Recent Developments & Impact Analysis, By Key Market Participants
                  6.2. Company/Competition Categorization
                      6.2.1. Innovators
                  6.3. Vendor Landscape
                      6.3.1. List of key distributors and channel partners
                      6.3.2. Key customers
                      6.3.3. Key company market share analysis, 2018
                      6.3.4. Abbott Laboratories
                          6.3.4.1. Company overview
                          6.3.4.2. Financial performance
                          6.3.4.3. Product benchmarking
                          6.3.4.4. Strategic initiatives
                      6.3.5. Medtronic Plc
                          6.3.5.1. Company overview
                          6.3.5.2. Financial performance
                          6.3.5.3. Product benchmarking
                          6.3.5.4. Strategic initiatives
                      6.3.6. F Hoffmann -La Roche Ltd
                          6.3.6.1. Company overview
                          6.3.6.2. Financial performance
                          6.3.6.3. Product benchmarking
                          6.3.6.4. Strategic initiatives
                      6.3.7. Bayer AG
                          6.3.7.1. Company overview
                          6.3.7.2. Financial performance
                          6.3.7.3. Product benchmarking
                          6.3.7.4. Strategic initiatives
                      6.3.8. Becton, Dickinson, and Company
                          6.3.8.1. Company overview
                          6.3.8.2. Financial performance
                          6.3.8.3. Product benchmarking
                          6.3.8.4. Strategic initiatives
                      6.3.9. Ypsomed AG
                          6.3.9.1. Company overview
                          6.3.9.2. Financial performance
                          6.3.9.3. Product benchmarking
                          6.3.9.4. Strategic initiatives
                      6.3.10. Dexcom, Inc
                          6.3.10.1. Company overview
                          6.3.10.2. Financial performance
                          6.3.10.3. Product benchmarking
                          6.3.10.4. Strategic initiatives
                      6.3.11. Novo Nordisk A/S
                          6.3.11.1. Company overview
                          6.3.11.2. Financial performance
                          6.3.11.3. Product benchmarking
                          6.3.11.4. Strategic initiatives
                      6.3.12. Arkray, Inc
                          6.3.12.1. Company overview
                          6.3.12.2. Financial performance
                          6.3.12.3. Product benchmarking
                          6.3.12.4. Strategic initiatives
                      6.3.13. Sanofi
                          6.3.13.1. Company overview
                          6.3.13.2. Financial performance
                          6.3.13.3. Product benchmarking
                          6.3.13.4. Strategic initiatives
                      6.3.14. Acon Laboratories, Inc
                          6.3.14.1. Company overview
                          6.3.14.2. Financial performance
                          6.3.14.3. Product benchmarking
                          6.3.14.4. Strategic initiatives

List of Tables

Table 1 List of abbreviation
Table 2 BRIC diabetes care devices market, by region, 2015 - 2026 (USD Million)
Table 3 BRIC diabetes care devices market, by product, 2015 - 2026 (USD Million)
Table 4 BRIC diabetes care devices market, by BGM devices, 2015 - 2026 (USD Million)
Table 5 BRIC diabetes care devices market, by CGM devices, 2015 - 2026 (USD Million)
Table 6 BRIC diabetes care devices market, by insulin delivery devices, 2015 - 2026 (USD Million)
Table 7 Brazil diabetes care devices market, by product, 2015 - 2026 (USD Million)
Table 8 Brazil diabetes care devices market, by BGM devices, 2015 - 2026 (USD Million)
Table 9 Brazil diabetes care devices market, by CGM devices, 2015 - 2026 (USD Million)
Table 10 Brazil diabetes care devices market, by insulin delivery devices, 2015 - 2026 (USD Million)
Table 11 Russia diabetes care devices market, by product, 2015 - 2026 (USD Million)
Table 12 Russia diabetes care devices market, by BGM devices, 2015 - 2026 (USD Million)
Table 13 Russia diabetes care devices market, by CGM devices, 2015 - 2026 (USD Million)
Table 14 Russia diabetes care devices market, by insulin delivery devices, 2015 - 2026 (USD Million)
Table 15 India diabetes care devices market, by product, 2015 - 2026 (USD Million)
Table 16 India diabetes care devices market, by BGM devices, 2015 - 2026 (USD Million)
Table 17 India diabetes care devices market, by CGM devices, 2015 - 2026 (USD Million)
Table 18 India diabetes care devices market, by insulin delivery devices, 2015 - 2026 (USD Million)
Table 19 China diabetes care devices market, by product, 2015 - 2026 (USD Million)
Table 20 China diabetes care devices market, by BGM devices, 2015 - 2026 (USD Million)
Table 21 China diabetes care devices market, by CGM devices, 2015 - 2026 (USD Million)
Table 22 China diabetes care devices market, by insulin delivery devices, 2015 - 2026 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in BRIC
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 BRIC diabetes care devices market, 2018
Fig. 10 BRIC diabetes care devices market segmentation
Fig. 11 BRIC diabetes care devices market Trends
Fig. 12 BRIC diabetes care devices market driver impact
Fig. 13 BRIC diabetes care devices market restraint impact
Fig. 14 Penetration & Growth Prospect Mapping
Fig. 15 BRIC diabetes care devices market - PESTLE Analysis
Fig. 16 Industry Analysis - Porter's
Fig. 17 BRIC diabetes care devices market competitive landscape: Market position analysis (Based on products, regional presence)
Fig. 18 BRIC diabetes care devices market: Product outlook key takeaways
Fig. 19 BRIC diabetes care devices market: Product movement analysis
Fig. 20 BRIC diabetes care devices market: application outlook key takeaways
Fig. 21 BRIC diabetes care devices market, type outlook, 2015 - 2026 (USD Million)
Fig. 22 Regional marketplace, 2015 - 2026 (USD Million)
Fig. 23 BRIC diabetes care devices market, 2015 - 2026 (USD Million)
Fig. 24 Brazil diabetes care devices market, 2015 - 2026 (USD Million)
Fig. 25 Russia diabetes care devices market, 2015 - 2026 (USD Million)
Fig. 26 India diabetes care devices market, 2015 - 2026 (USD Million)
Fig. 27 China diabetes care devices market, 2015 - 2026 (USD Million)